AFEW International released the COVID-19 report “Interruption and Innovation” with an overview of disruptions of and responses to prevention, treatment and care for key populations at risk for HIV, TB and viral hepatitis due to Covid-19 in Eastern Europe and Central Asia.
The purpose of this document, commissioned by AFEW International, is to provide an overview of the impact of the pandemic with the novel coronavirus (SARS-CoV-2) and its associated disease, COVID-19, on the continuity of prevention, treatment and care of HIV, Tuberculosis, viral hepatitis and other relevant diseases in Eastern Europe and Central Asia (EECA).
The regional scope of this report includes the countries Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Ukraine and Uzbekistan.
This report will pay special attention to the impact of measures to prevent COVID-19 on disruptions of services for key- and vulnerable populations to the diseases mentioned earlier. These key- and vulnerable populations are: people who inject drugs, sex workers, men who have sex with men, trans people, people living with HIV, people deprived of liberty like people in prison or pre-trial detention, tuberculosis patients and their contacts, labour migrants, refugees and internally displaced people.
Dopasi Foundation @Dopasifoundaton
Fri, 08/07/2020 - 07:48
RT @tb_ppm: Congratulations! Looking forward collaborating on private provider engagement in TB.
@Dopasifoundaton @ClintonHealth @PSKenya…
James Malar @MalarJames
Sat, 08/01/2020 - 09:40
RT @TBECoalition: For your attention! An Activist’s Guide to Tuberculosis Diagnostic Tools.
These resources are designed to help activists…